Abstract

Developments of new strategies to restore vision and improving on current strategies by harnessing new advancements in material and electrical sciences, and biological and genetic-based technologies are of upmost health priorities around the world. Federal and private entities are spending billions of dollars on visual prosthetics technologies. This review describes the most current and state-of-the-art bioengineering technologies to restore vision. This includes a thorough description of traditional electrode-based visual prosthetics that have improved substantially since early prototypes. Recent advances in molecular and synthetic biology have transformed vision-assisted technologies; For example, optogenetic technologies that introduce light-responsive proteins offer excellent resolution but cortical applications are restricted by fiber implantation and tissue damage. Other stimulation modalities, such as magnetic fields, have been explored to achieve non-invasive neuromodulation. Miniature magnetic coils are currently being developed to activate select groups of neurons. Magnetically-responsive nanoparticles or exogenous proteins can significantly enhance the coupling between external electromagnetic devices and any neurons affiliated with these modifications. The need to minimize cytotoxic effects for nanoparticle-based therapies will likely restrict the number of usable materials. Nevertheless, advances in identifying and utilizing proteins that respond to magnetic fields may lead to non-invasive, cell-specific stimulation and may overcome many of the limitations that currently exist with other methods. Finally, sensory substitution systems also serve as viable visual prostheses by converting visual input to auditory and somatosensory stimuli. This review also discusses major challenges in the field and offers bioengineering strategies to overcome those.

Highlights

  • The development of bioelectrical interfaces in the 18th century enthralled scientists looking for strategies to treat brain pathologies and restore vision

  • This review describes state-of-the-art electrode-based visual prostheses technologies, and the ongoing development of cutting-edge biological- and genetic-based technologies to restore visual function including nanoparticles, optogenetics, magnetic manipulation and sensory substitution systems

  • Optogenetic technologies that introduce light-responsive proteins offer excellent resolution but cortical applications are restricted by fiber implantation and tissue damage

Read more

Summary

INTRODUCTION

The development of bioelectrical interfaces in the 18th century enthralled scientists looking for strategies to treat brain pathologies and restore vision. Visual prostheses allowing for the restoration of basic abilities promoting object discrimination (Stingl et al, 2013) and simple mobility (Humayun et al, 2012), are viable therapeutic considerations for visually impaired and blind individuals. This review describes state-of-the-art electrode-based visual prostheses technologies, and the ongoing development of cutting-edge biological- and genetic-based technologies to restore visual function including nanoparticles, optogenetics, magnetic manipulation and sensory substitution systems. These methods have the capability of artificially encoding sensation i.e. In 2015, there were 253 million individuals (3.43% of global population) blind and moderately-to-severely visually impaired people in the world (Bourne et al, 2017).

Limitations
Findings
CONCLUSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call